ArticleCureus2025
Naloxone Co-prescription in Chronic Opioid Therapy: Benefits, Pitfalls, and Lessons Learned.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
There has been a well-publicized epidemic of lethal and non-lethal prescription opioid overdose in the United States. Significant efforts have been made to alter this trajectory, both at the public health and direct medical care levels. One specific method of harm reduction has been the co-prescription of intranasal naloxone to all patients who are prescribed chronic opioids. In this editorial, we discuss our experience of instituting this quality improvement initiative within a large academic pain management center. After an adverse event of inadvertent administration of intranasal naloxone precipitating opioid withdrawal and emergency evaluation, we learned several lessons. These lessons include cultural sensitivity, being specific on prescription instructions, and how to best discuss naloxone co-prescription with our patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.